HOME > Investors > Press Releases
2012-09-24
ViroMed announces final patient enrollment for VM202-PAD phase II clinical trial in US/Korea
2012-08-31
[Biospectrum. Aug. 2012] One drug for three diseases
2012-04-13
Approval from the Korea FDA for a Phase II clinical trial for diabetic peripheral neuropathy
2012-04-06
ViroMed’s PG201 receives market approval
2012-03-14
ViroMed Presents Results of VM202 Clinical Trials at FPN Symposium
1 2 3 4 5 6 7 8 9 10